Furthermore, in discussion, authors stated that the principal aim of the study was to determine the success rates for long-term intraocular pressure (IOP) control after 'primary' conventional Trabeculectomy with MMC in OAG versus ACG and the need for further treatment either medical or surgical, implying that the patients were treatment-naïve. However, patients were on pre-operative medications and post-operative change has been analysed and presented. Cite this article as: Pathak-Ray V. Comments on: Mid-term outcome of mitomycin C-augmented trabeculectomy in open-angle glaucoma versus angle-closure glaucoma. Indian J Ophthalmol 2020;68:267-8.
In their cohort, over 40% of patients required argon laser suturelysis; nonetheless, surgical methodology describes standard usage of releasable suture. Information about release of the latter is not forthcoming. Also, if laser was available for suturelysis, then addition of releasable suture per-se to the surgical procedure appears to be expendable.
Outcomes of success were determined by IOP ≤21 mmHg with no defined lower limit. Yet hypotony was a complication seen in a few eyes. It will be helpful if the authors can define the cut-off level of IOP at which this was determined and the duration it took for these cases to settle down. Also, it would make compelling reading if success rates in both groups were to be provided at the lower target IOP of 18 mmHg. [2] Finally, the conclusion appear a little confusing with the statement that 'surgical outcome is as good as a normal eye' -in as much as a glaucomatous eye with a bleb is a far cry from a normal one.
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Response to comments on: Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle-closure glaucoma
Dear Sir, We thank Pathak-Ray [1] for her comments on our article "Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle closure glaucoma". [2] This study was designed to evaluate the midterm outcome of trabeculectomy retrospectively in a series of consecutive cases of open angle glaucoma (OAG) and angle closure glaucoma (ACG) that had undergone trabeculectomy with mitomycin C. Primary trabeculectomies were performed with mitomycin C during the period of the study. Retrospective analysis of 108 out of 137 eyes was included in this study. However, 14 patients had less than 1 year of follow-up and the remaining 15 patients were excluded because of insufficient hospital records.
In our cohort, the first primary surgical treatment offered to the patients was trabeculectomy with mitomycin C. In the surgical technique, the scleral flap was repositioned in place using three 10-0 nylon sutures; one releasable suture was put for the apical suture out of three sutures and the remaining two were interrupted sutures. Argon laser suture lysis was done later for the remaining two sutures accordingly. [3] The cutoff levels for the range of intraocular pressure (IOP) were taken as ≤21 mmHg as the upper limit on the basis of major clinical trials and ≥6 mmHg as the lower limit. [4, 5] Two cases of angle closure glaucoma developed hypotony in our study. Hypotony was defined as IOP ≤6 mmHg and it took 3 months for those cases to settle down. [6, 7] Financial support and sponsorship Nil.
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Department of Glaucoma, Aravind Eye Hospital and Post-Graduate Institute of Ophthalmology, Tirunelveli, Tamil Nadu, India profile of uveitis patients developing central serous chorioretinopathy -An experience at a tertiary eye care center in India Dear Sir, We thank the authors for taking great interest in our paper and their comments. [1] However, considering the etiological heterogeneity in our case series with a varied spectrum of uveitic patients, any attempt to generalize the association of central serous chorioretinopathy (CSC) may not be straightforward. For example, it will be difficult to calculate the cumulative dose of steroids in our patients-as 6 of our 26 patients were using topical steroids, and 2 developed CSC following periocular steroid injections. [2] Moreover, the development of CSC is not always dose-dependent. Further, corticosteroid, in any form, is usually avoided in patients with a history of CSC and none of our patients had a history of CSC. All of the patients in our case series had varying degrees of inflammation at the time of diagnosis, and the subsequent management of these cases has already been described in the paper. [2] It is always challenging to manage a case of uveitis in the presence of CSC as many a time the cause of decrease in vision is interpreted as worsening of the primary inflammation. Two of our six patients with CSC who presented with bullous retinal detachment were started on high-dose corticosteroids, elsewhere misinterpreting them as worsening of Vogt-Koyanagi-Harada disease (VKH). It is of utmost importance to differentiate between the two entities as the modalities of treatment are quite opposite; while steroids help resolve inflammation in VKH, they are contraindicated in CSC. A combination of ophthalmoscopic and angiographic findings is usually helpful to clinch the correct diagnosis in such scenario. VKH syndrome, sympathetic ophthalmia, and posterior scleritis have a similar angiographic characteristic; the multiple pinpoint hyperfluorescence in early frames show placoid pooling in late frames whereas the leaks in CSC increases in size and intensity. In addition, the lack of optic disc staining in CSC is an important feature. [3] Indocyanine green angiography may rescue the clinician in differentiating such scenarios. Furthermore, optical coherence tomography examination in VKH can show subretinal septa with a multilobular exudative retinal detachment and undulating folds of the retinal pigment epithelium and Bruch membrane. The clinical sign like a "dark spot" and multiple pigment epithelial detachment (PED) seen on imaging can help differentiate the two. [4] PED is uncommon in inflammatory conditions. However, the absence of PED does not rule out CSC as non-PED CSC is more common especially in the acute state of first attack. We agree that in the presence of ocular inflammation, signs of CSC might be overlooked. This, precisely, was among the primary purposes of describing the case series highlighting the management difficulties of such situations. The diagnosis of such cases require a high index of suspicion and appropriate interpretation of ancillary investigations.
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